Softgel Capsules Market Size Worth USD 16.96 Billion by 2034 | CAGR: 7.96%

Softgel Capsules Market Size Worth USD 16.96 Billion by 2034 | CAGR: 7.96%


The global softgel capsules market size is expected to reach USD 16.96 billion by 2034, according to a new study by Polaris Market Research. The report “Softgel Capsules Market Size, Share, Trends, Industry Analysis Report: By Type (Gelatin-Based/Animal-Based and Non-Animal-Based), Application, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2026–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The softgel capsules market encompasses the production, distribution, and consumption of encapsulated dosage forms featuring a soft, pliable outer shell, typically made from gelatin or vegetarian alternatives, containing liquid or semi-solid fill materials. These capsules serve as a preferred delivery method for pharmaceuticals, nutraceuticals, and cosmeceuticals, offering advantages such as ease of swallowing, improved bioavailability, and the ability to mask unpleasant tastes or odors. The market is characterized by a diverse range of applications, catering to various therapeutic areas and consumer health needs.

An overview of the market reveals a dynamic landscape driven by increasing consumer awareness of preventive healthcare, technological advancements in encapsulation, and the growing geriatric population. The rising demand for dietary supplements, coupled with the pharmaceutical industry's focus on enhancing drug delivery systems, is propelling market expansion. Key softgel capsules market trends include the adoption of vegetarian softgels, customized formulations, and the expansion of contract manufacturing organizations. The market is also influenced by stringent regulatory standards and the need for high-quality, reliable softgel solutions, shaping the competitive environment and driving innovation.

Softgel Capsules Market Report Highlights

  • North America holds the largest market revenue share of 36.50% in 2025. The presence of a robust pharmaceutical industry and high consumer adoption of dietary supplements drive the region’s leading market share.
  • Asia Pacific is witnessing the highest growth rate at a CAGR of 9.50%. Rising disposable incomes and a rapidly expanding healthcare sector fuel market growth in the region.
  • In 2025, the gelatin-based/animal-based segment accounts for a larger market share of 72.0%. The segment’s long-established use and cost-effectiveness in nutraceutical and pharmaceutical products contribute to its leading market position.
  • The pregnancy segment is registering the fastest growth at a CAGR of 7.70%, owing to increasing awareness of prenatal nutrition.
  • The pharmaceutical companies segment leads the market with 43.0% share in 2025, primarily due to the extensive use of softgel capsules for drug delivery in various therapeutic areas.
  • Key players active in the softgel capsules market include Aenova Holding GmbH; Best Formulations; CAPTEK Softgel International, Inc.; Catalent, Inc.; Fuji Capsule Co., Ltd.; Ourvita; Procaps Group S.A.; Robinson Pharma, Inc.; SIRIO Pharma Co., Ltd.; Soft Gel Technologies, Inc.; Thermo Fisher Scientific Inc.

Request a free sample copy or read the full market insights: Softgel Capsules Market

Polaris Market Research has segmented the market report on the basis of type, application, end use, and region:

By Type Outlook (Revenue-USD Billion, 2021–2034)

  • Gelatin-Based/Animal-Based
  • Non-Animal-Based

By Application Outlook (Revenue-USD Billion, 2021–2034)

  • Antacid & Anti-Flatulent Preparation
  • Anti-Anemic Preparations
  • Anti-Inflammatory Drugs
  • Antibiotic & Antibacterial Drugs
  • Cough & Cold Preparations
  • Health Supplement
  • Vitamin & Dietary Supplement
  • Pregnancy

By End Use Outlook (Revenue-USD Billion, 2021–2034)

  • Pharmaceutical Companies
  • Nutraceutical Companies
  • Cosmeceutical Companies
  • Contract Manufacturing Organizations

By Regional Outlook (Revenue-USD Billion, 2021–2034)

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Netherlands
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Malaysia
    • South Korea
    • Indonesia
    • Australia
    • Vietnam
    • Rest of Asia Pacific
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Israel
    • South Africa
    • Rest of the Middle East & Africa
  • Latin America
    • Mexico
    • Brazil
    • Argentina
    • Rest of Latin America
Download Sample